data

Patients

Is women’s health reaching an inflection point?

A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.

R&D

Regulatory setback or scientific signal? The case for human-...

Exploring a systemic challenge in translating biological promise into reliable human efficacy and safety.

Digital

The practical path to AI: Boosting field productivity in bio...

R&D

Doctor looking at the data in healthcare setting

From data to impact: How real-world evidence will transform ...

Real-world evidence (RWE) has moved from the periphery to the centre of how healthcare decisions are made.

R&D

The irony of data in precision medicine: Igniting progress w...

As I regularly engage with pharma executives and biotech founders, a common theme inevitably arises: why is precision medicine taking so long to become a reality, and is technology to blame

Digital

Tech & Trials: Can AI save us from drowning in data?

Data – it’s everywhere! Especially in clinical trials, where an average trial of about 2,000 patients can expect to produce 3,000,000 points of data.